Wat heescht "Clear"?
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
Cerebellar Hypoplasia (CHP) in Eurasier dogs is a genetic condition affecting coordination and balance. Early DNA testing for CHP helps breeders identify carriers and prevent passing this neurological disorder to puppies. By using a reliable DNA test, Eurasier owners can ensure healthier litters and improve overall breed health. Understanding the genetic risks of CHP allows for informed breeding decisions and better management of affected dogs. Regular screening is essential for maintaining the Eurasier’s quality of life and vitality. Invest in a DNA test for Cerebellar Hypoplasia to protect your Eurasier’s future. Stay proactive in safeguarding your dog’s health with advanced genetic testing.
The DNA test for Cerebellar Hypoplasia in Eurasier (CHP) helps identify carriers of this genetic disorder. CHP affects the development of the cerebellum, leading to coordination and balance issues in affected dogs. By testing, breeders can make informed decisions to avoid producing affected puppies. Early detection through DNA testing promotes healthier breeding practices within the Eurasier community. This test is a valuable tool for maintaining the breed’s overall health and well-being.
Dësen DNA Test ass abegraff ab eisem Pack Basic - an ass och Deel vun de Pak Basic, Standard, Advanced, Complete.
View DNA Test Packs →Cerebellar Hypoplasia (CHP) is a neurological condition characterized by the underdevelopment of the cerebellum, a part of the brain responsible for coordinating movement and balance. In Eurasier dogs, this genetic disorder can lead to a range of motor difficulties, affecting their ability to walk, run, and perform other physical activities. Symptoms often manifest early in a dog’s life, typically within the first few months, and can vary in severity from mild to profound impairment.
The condition is caused by specific genetic mutations that disrupt normal cerebellar development. These mutations can be identified through DNA testing, which allows breeders and owners to determine the genetic predisposition of their dogs towards CHP. Understanding the genetic basis of this condition is crucial for responsible breeding practices, as it helps reduce the risk of passing on the disorder to future generations.
Dogs with Cerebellar Hypoplasia may exhibit a range of symptoms that can include uncoordinated movements, difficulty maintaining balance, and an abnormal gait. Some affected dogs may also display tremors or exhibit a wide stance when walking. Diagnosis typically involves a combination of clinical examination and genetic testing to confirm the presence of mutations associated with the condition. It is essential for owners to consult with a veterinarian if they suspect their dog may be affected, as early diagnosis can aid in managing the symptoms effectively.
While there is currently no cure for Cerebellar Hypoplasia, various management strategies can help improve the quality of life for affected dogs. These may include physical therapy, which can enhance muscle strength and coordination, and environmental modifications to create a safe living space. Providing a supportive and loving environment is crucial, as dogs with CHP can lead fulfilling lives despite their challenges.
DNA testing plays a vital role in breeding programs aimed at minimizing the incidence of Cerebellar Hypoplasia in Eurasier dogs. By identifying carriers of the genetic mutations linked to this condition, breeders can make informed decisions to avoid breeding practices that may perpetuate the disorder. This proactive approach not only helps maintain the health of the breed but also promotes overall responsible breeding ethics.
Cerebellar Hypoplasia in Eurasier dogs is a serious genetic condition that impacts their neurological function and quality of life. Through understanding the genetic basis, symptoms, and management of CHP, owners and breeders can work together to address this disorder. DNA testing serves as a critical tool in identifying at-risk animals and fostering healthier breeding practices, ultimately leading to a stronger and more resilient breed.
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
Nee D'Déier ass allgemeng gesond mee kann d'Mutatioun un seng iwwerdroen Nofolger.
Et huet zwee mutéiert Exemplare. Klinesch Zeeche ginn erwaart jee no der Krankheet. Et soll net gefeelt ginn.
E puer Krankheeten sinn Geschlecht verbonnen, sou datt hiren Ausdrock variéiert jee no der Geschlecht vum Déier.
This DNA test detects the mutation associated with Cerebellar Hypoplasia In Eurasier (CHP-E) in order to identify clear, carrier, or at-risk animals.
DNA Testen hëlleft Züchter méi sécher Maten ze plangen an de Risiko ze reduzéieren fir d'Mutatioun un d'Nofolger ze iwwerdroen.
Den Ierfschaftsmodus fir dësen Test gemellt ass Autosomal Recessive.
This test analyses the mutation VLDLR c.1713delC.
Net onbedéngt. D'Interpretatioun hänkt vum Ierfschaftsmuster an dem resultéierende Genotyp of.
Gerber Martina, Fischer Andrea, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord, Schmidt Martin J, Bernardino Filipa, Manz Eberhard, Matiasek Kaspar, Rentmeister Kai, Leeb Tosso. A deletion in the VLDLR gene in Eurasier dogs with cerebellar hypoplasia resembling a Dandy-Walker-like malformation (DWLM). PLoS One. 2015 Feb 10;10(2):e0108917. doi: 10.1371/journal.pone.0108917. eCollection 2015.
Är Privatsphär, Äre Choix
Mir benotze wesentlech Cookien fir d'Websäit ze lafen. Optional Cookien (wéi embedded Inhalt Provider) sinn als Standard deaktivéiert a sinn nëmmen aktivéiert wann Dir averstanen ass. Dir kënnt Äre Choix zu all Moment mat der "Cookien" Knäppchen änneren.
Néideg fir Kär Funktiounen a Sécherheet. Ëmmer aktivéiert.
Verbessert Funktiounen wéi Präferenz spueren oder Net-Reklamm Embeds.
Hëlleft eis d'Benotzung vum Site ze verstoen. Standard behënnert.
Annoncéieren / Tracking iwwer Siten (e puer Video / Kaarten embeds). Standard behënnert.